Primary malignant neoplasm
|
0.090 |
Biomarker
|
group |
BEFREE |
All compounds were evaluated for their cytotoxic activities against three human cancer cell lines: A375 (melanoma), A549 (lung), and PLC (hepatoma).
|
29421242 |
2018 |
Primary malignant neoplasm
|
0.090 |
Biomarker
|
group |
BEFREE |
Selective expression of heparan sulfate (HS) proteoglycans syndecan-1 and perlecan in the AG2 colon cancer-initiating cell line suggests these PGs as potential biomarkers for cancer stem cells.
|
25715761 |
2015 |
Primary malignant neoplasm
|
0.090 |
Biomarker
|
group |
BEFREE |
These studies implicate perlecan in cytokine-mediated, innate tissue responses to cancer cell invasion, a process we suggest reflects a modified wound healing tissue response co-opted by prostate cancer cells.
|
24700612 |
2014 |
Primary malignant neoplasm
|
0.090 |
AlteredExpression
|
group |
BEFREE |
We demonstrated that macrophages stimulate cancer cell invasion, motility and migration, and that these effects depend on matrix metalloproteinase (MMP) activity and on the activation of epidermal growth factor receptor (EGFR) (at the residue Y(1086)), PLC-γ (phospholipase C-gamma) and Gab1 (GRB2-associated binding protein-1), as evidenced by siRNA (small interference RNA) experiments.
|
23644655 |
2014 |
Primary malignant neoplasm
|
0.090 |
Biomarker
|
group |
BEFREE |
Taken together, our results show a previously unidentified tumor suppressor role for this PLC in animal models and, together with observations of marked down-regulation in colorectal, lung, and skin tumors, suggest its use as a biological marker in cancer.
|
24591640 |
2014 |
Primary malignant neoplasm
|
0.090 |
Biomarker
|
group |
BEFREE |
Matrix-accumulated PGs, such as versican, perlecan and small leucine-rich PGs, affect cancer cell signaling, growth and survival, cell adhesion, migration and angiogenesis.
|
20840587 |
2010 |
Primary malignant neoplasm
|
0.090 |
Biomarker
|
group |
BEFREE |
By more fully understanding perlecan's functioning in angiogenesis, we may gain invaluable insight that could lead to therapeutic interventions in cancer and other pathologic states.
|
18300285 |
2008 |
Primary malignant neoplasm
|
0.090 |
AlteredExpression
|
group |
BEFREE |
Among 7 hepatoma cell lines analyzed, 5-alpha-fetoprotein (AFP)-producing hepatoma cell lines (HepG2, Huh7, Hep3B, PLC/PRF/5, and Huh6) were shown to have common gene-expression profiles compared with those of AFP-negative hepatoma cell lines (HLE and SK-Hep1) and cancer cell lines of nonhepatocyte origin (HeLa and KMBC).
|
11230749 |
2001 |
Primary malignant neoplasm
|
0.090 |
Biomarker
|
group |
BEFREE |
To test the role of perlecan in malignancy, we generated several stably transfected clones of HT-1080, a human fibrosarcoma cell line, harboring a perlecan cDNA in the antisense orientation.
|
9187109 |
1997 |